Leerink Partnrs Has Positive Outlook of PRVA FY2025 Earnings

Key Points

• Leerink Partners has raised its FY2025 earnings per share (EPS) estimate for Privia Health Group to $0.23, while the consensus estimate is currently $0.14 per share.
• Privia Health Group reported a revenue of $521.15 million for the last quarter, exceeding the consensus estimate of $466.97 million, despite missing EPS estimates.
• The stock has received mostly positive ratings from analysts, with a consensus rating of "Moderate Buy" and an average target price of $28.58.

Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) - Stock analysts at Leerink Partnrs raised their FY2025 EPS estimates for Privia Health Group in a research report issued on Tuesday, September 23rd. Leerink Partnrs analyst W. Mayo now forecasts that the company will post earnings per share of $0.23 for the year, up from their previous estimate of $0.21. The consensus estimate for Privia Health Group's current full-year earnings is $0.14 per share. Leerink Partnrs also issued estimates for Privia Health Group's Q4 2025 earnings at $0.09 EPS, Q4 2026 earnings at $0.12 EPS, FY2026 earnings at $0.42 EPS, FY2027 earnings at $0.57 EPS, FY2028 earnings at $0.76 EPS and FY2029 earnings at $0.99 EPS.

Privia Health Group (NASDAQ:PRVA - Get Free Report) last released its earnings results on Thursday, August 7th. The company reported $0.02 earnings per share for the quarter, missing the consensus estimate of $0.05 by ($0.03). Privia Health Group had a net margin of 0.78% and a return on equity of 2.13%. The firm had revenue of $521.15 million during the quarter, compared to the consensus estimate of $466.97 million. During the same period in the prior year, the business posted $0.19 earnings per share. Privia Health Group's quarterly revenue was up 23.4% compared to the same quarter last year. Privia Health Group has set its FY 2025 guidance at EPS.

PRVA has been the subject of a number of other reports. JPMorgan Chase & Co. lifted their price objective on shares of Privia Health Group from $29.00 to $32.00 and gave the stock an "overweight" rating in a research report on Wednesday, May 28th. Stephens reaffirmed an "overweight" rating and set a $32.00 price objective on shares of Privia Health Group in a research report on Wednesday. Zacks Research raised shares of Privia Health Group from a "strong sell" rating to a "hold" rating in a research report on Tuesday, August 19th. JMP Securities lifted their price objective on shares of Privia Health Group from $29.00 to $30.00 and gave the stock a "market outperform" rating in a research report on Friday, August 29th. Finally, Piper Sandler reduced their price objective on shares of Privia Health Group from $36.00 to $35.00 and set an "overweight" rating for the company in a research report on Monday, August 11th. One investment analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $28.58.

Privia Health Group Trading Down 0.6%

NASDAQ:PRVA opened at $23.34 on Thursday. Privia Health Group has a 1-year low of $16.47 and a 1-year high of $26.09. The firm has a fifty day simple moving average of $21.39 and a 200 day simple moving average of $22.40. The stock has a market capitalization of $2.86 billion, a PE ratio of 212.20, a P/E/G ratio of 3.40 and a beta of 0.82.

Institutional Investors Weigh In On Privia Health Group

Institutional investors have recently modified their holdings of the business. CWM LLC boosted its position in shares of Privia Health Group by 50.3% in the first quarter. CWM LLC now owns 1,804 shares of the company's stock valued at $40,000 after acquiring an additional 604 shares during the period. Bessemer Group Inc. boosted its position in shares of Privia Health Group by 2,393.4% in the first quarter. Bessemer Group Inc. now owns 2,269 shares of the company's stock valued at $51,000 after acquiring an additional 2,178 shares during the period. Russell Investments Group Ltd. boosted its position in shares of Privia Health Group by 2,852.2% in the first quarter. Russell Investments Group Ltd. now owns 2,657 shares of the company's stock valued at $60,000 after acquiring an additional 2,567 shares during the period. GAMMA Investing LLC lifted its position in Privia Health Group by 113.1% during the first quarter. GAMMA Investing LLC now owns 2,866 shares of the company's stock worth $64,000 after purchasing an additional 1,521 shares during the period. Finally, Caitong International Asset Management Co. Ltd lifted its position in Privia Health Group by 2,115.3% during the first quarter. Caitong International Asset Management Co. Ltd now owns 3,323 shares of the company's stock worth $75,000 after purchasing an additional 3,173 shares during the period. Institutional investors own 94.48% of the company's stock.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.